Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy
about
Clinical Spectrum of Stiff Person Syndrome: A Review of Recent ReportsGuidelines for treatment of immune-mediated cerebellar ataxiasNeuronal central nervous system syndromes probably mediated by autoantibodiesLong latency between GAD-antibody detection and development of limbic encephalitis--a case report.Antibodies to aquaporin 4, myelin-oligodendrocyte glycoprotein, and the glycine receptor α1 subunit in patients with isolated optic neuritisParaneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.Pathogenic Roles of Glutamic Acid Decarboxylase 65 Autoantibodies in Cerebellar AtaxiasConsensus Paper: Neuroimmune Mechanisms of Cerebellar Ataxias.GAD Antibody-Associated Late-Onset Cerebellar Ataxia in Two Female SiblingsAntibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxylase autoimmunity.Paraneoplastic disordersClinical and Immunologic Investigations in Patients With Stiff-Person Spectrum DisorderTreatable causes of cerebellar ataxia.Immune therapy in autoimmune encephalitis: a systematic review.Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies.Ataxia in children: early recognition and clinical evaluation.Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System.Cerebellar disease associated with anti-glutamic acid decarboxylase antibodies: review.Immune-mediated cerebellar ataxias: from bench to bedside.Treatment of Cerebellar Ataxia in the Context of Systemic Diseases.Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology.Low-Titre GAD Antibody-Associated Late-Onset Cerebellar Ataxia with a Significant Clinical Response to Intravenous Immunoglobulin Treatment.Cerebellar ataxia and autoantibodies restricted to glutamic acid decarboxylase 67 (GAD67).Acute Cerebellar Ataxia Associated with Anti-glutamic Acid Decarboxylase Antibodies Mimicking Miller Fisher Syndrome.Clinical characteristics of patients with cerebellar ataxia associated with anti-GAD antibodies.GAD65 neurological autoimmunity.Aberrant cerebellar Purkinje cell function repaired in vivo by fusion with infiltrating bone marrow-derived cells.Metabolic topography of autoimmune non-paraneoplastic encephalitis.The clinical features, underlying immunology, and treatment of autoantibody-mediated movement disordersPragmatic Treatment of Stiff Person Spectrum DisordersFurther reducing on the map of synaptic autoimmunity
P2860
Q26753841-2E233BC4-046E-460B-BFF3-9479D0A95F9BQ26777428-4C900CEA-9DC5-4FF8-85DB-CF84506862D2Q28072253-B16146D9-0532-4CDD-9B8A-FBB4F554B091Q30401723-25AC82A9-32D0-4A7D-A1FF-78F53DA57363Q34453889-A192D872-9875-4FD1-8B1E-62776FD50BBFQ34481818-CD8B9A3C-0B6F-4B87-A775-FDC99EC65825Q34554924-14402007-2B1D-4674-B92F-7E01C732A650Q34669020-03F08111-C4B9-4B5B-870B-FE1AD9034994Q34792143-50FCE5D9-AA60-4B2C-9B56-81300C757614Q35182392-1A4B405A-C268-42CF-879F-F3991BA0F268Q35646721-5313D717-E32B-4E34-A15D-3BEECDA02954Q37250508-E2EFB2D8-0FFE-41A9-A7DA-C70605EC5B61Q38372235-18F33368-3B71-4CC2-934A-2EE7548BB743Q38630867-A764E03D-7215-4641-9303-0C01A0972B82Q38726369-309E2D31-3983-4C9B-A4A2-E0CE450BF2A3Q39160132-C85F40AA-6DDA-4CF6-8A85-196E50784232Q39180685-90291A5B-55D1-4040-83D7-BA8810553542Q39423412-9A0895D2-2355-47F4-9717-B1F1A93670A7Q41695892-D7461B52-7332-4701-8390-0E5E222F959EQ47159668-000153E7-517F-4326-81C7-E4C0BEEF2AB1Q47623969-5AF45BC2-8854-495B-BCCC-6C17DAA4B116Q48100215-72670F4A-5B4E-4578-95B3-BC33BBAA7AB5Q50224993-F59F958B-43F8-4EB0-A7B3-35C4EC59047DQ50314134-E4C51BEB-C6A5-4532-A4BE-5BFA67D3DDD8Q51081947-BDE87025-8D5B-4A74-845D-05D552D63012Q51210635-3E443B81-71D1-446F-970E-4FB9C97B63FDQ51733772-5E072B48-92C6-44CD-9A00-595A5DA8A42EQ52744681-73111EA0-D424-4BF9-8D61-B126CD1D1397Q57157350-A062F5C8-C224-45A9-BF0D-6145571B5D37Q58568103-53547063-3A62-4871-A21D-34CB384B27C7Q58802892-62529EA8-B93E-4432-BE84-B127253AB83E
P2860
Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Cerebellar ataxia and glutamic ...... g-term effect of immunotherapy
@en
type
label
Cerebellar ataxia and glutamic ...... g-term effect of immunotherapy
@en
prefLabel
Cerebellar ataxia and glutamic ...... g-term effect of immunotherapy
@en
P2093
P2860
P50
P1433
P1476
Cerebellar ataxia and glutamic ...... g-term effect of immunotherapy
@en
P2093
Albert Saiz
Idoia Rouco
Lidia Sabater
Luis Bataller
Nuria Gresa-Arribas
Yolanda Blanco
P2860
P304
P356
10.1001/JAMANEUROL.2014.1011
P407
P577
2014-08-01T00:00:00Z